Etomoxir (sodium salt)

Catalog No. A11415

Etomoxir (sodium salt)是肉碱棕榈酰转移酶A(CPT1)的抑制剂,它是长链酰基辅酶A酯氧化所必需的。也是线粒体CPT1的强抑制剂和抗糖尿病药物的候选药物。
  • A. Geneste, .et al. Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib, BMC Pharmacol Toxicol, 2020, 21: 61 PMID: 32795383
Catalog Num A11415
M. Wt 320.74
Formula C15H18ClO4.Na
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 828934-41-4 (sodium salt), 124083-20-1 (Base)
Synonyms (R)-(+)-Etomoxir
SMILES CCOC(=O)[C@]1(CO1)CCCCCCOC2=CC=C(C=C2)Cl
Etomoxir (sodium salt)是肉碱棕榈酰转移酶A(CPT1)的抑制剂,它是长链酰基辅酶A酯氧化所必需的。也是线粒体CPT1的强抑制剂和抗糖尿病药物的候选药物。
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 31.18 mL 155.89 mL 311.78 mL
0.5 mM 6.24 mL 31.18 mL 62.36 mL
1 mM 3.12 mL 15.59 mL 31.18 mL
5 mM 0.62 mL 3.12 mL 6.24 mL

*The above data is based on the productmolecular weight 320.74. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.